Conditional Prrx1 loss of function in Sm22 (Tagln) positive CAFs in a mouse model of pancreatic cancer also promoted in vitro an activated phenotype with an increase in ACTA2 and COL1 expression levels (Feldmann et al., 2021). Here, PRRX1 is linked to pancreatic neoplasm.